In The News


February 6, 2019

Transmural Systems receives FDA IDE

Approval for Transmural Cerclage Early Feasibility Study for 30 patients.

 

September 20, 2018

Transmural Systems Announces

SBIR, Phase 1 & 2 SBIR Grant Award from National

Institutes of Health, NHLBI for development of Devices for

Transcatheter Surgery

May 29, 2018

Transmural Systems Announces Phase IIB

for the continued development of T088, Transcaval Access

to the Abdominal Aorta from National Institutes of Health,

NHLBI

April 30, 2018

Transmural Systems Announces having

Successfully Completed Enrollment of 12 subjects in the

Transcaval Closure Device EFS.

November 16, 2017

Transmural Systems receives FDA

IDE Approval for Transmural Transcaval Closure Device

Early Feasibility Study (EFS) for 15 patients.

September 26, 2016

Transmural Systems Announces

SBIR, Direct to Phase II Grant Award from National

Institutes of Health, NHLBI for development of

Transcatheter Cavopulmonary Bypass Endograph

September 14, 2015

Transmural Systems Announces

SBIR, Direct to Phase II Grant Award from the National

Institutes of Health, NHLBI for development of Transcaval

Access to the Abdominal Aorta

July 1, 2015

Transmural Systems Announces Phase 1 &

2 SBIR Grant Award from National Institutes of Health,

NHLBI for development of Cerclage for Treating Secondary

Mitral Regurgitation.